SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

April 24, 2003

Date of Report
(Date of earliest event reported)

HUMAN GENOME SCIENCES, INC.

(Exact Name of Registrant as Specified in Charter)

Delaware	0-022962	22-3178468
(State or Other Jurisdiction of	(Commission File Number)	(IRS Employer Identification No.)
Incorporation)

9410 Key West Avenue, Rockville, Maryland                  20850-3338
(Address of Principal Executive Offices)                           (ZIP Code)

Registrant's telephone number, including area code: (301) 309-8504

(Former Name or Former Address, if Changed Since Last Report)

Item 9. Regulation FD Disclosure (Item 12, Disclosure of Results of Operations and Financial Condition).

     The following information is furnished pursuant to Item 12, "Disclosure of Results of Operations and Financial Condition":

     On April 24, 2003, Human Genome Sciences, Inc. issued a press release reporting its financial results for the three months ended March 31, 2003. The press release is attached hereto as Exhibit 99.1.

Item 7. Financial Statements and Exhibits.

     (c) Exhibits

Exhibit	Description
99.1	Press Release issued April 24, 2003

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	HUMAN GENOME SCIENCES, INC.
Date: April 24, 2003	By:	/s/ Steven C. Mayer Steven C. Mayer Senior Vice President and Chief Financial Officer